Dr. Yong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 E 98th St
New York, NY 10029Phone+1 212-241-5493Fax+1 212-831-3324
Summary
- I am an academic neurosurgeon with a clinical and research interest in malignant brain tumors. I completed medical school and residency training in Canada, as well as research training at MD Anderson Cancer Center, and fellowship training at the Surgical Neurology Branch, NIH Clinical Center. My laboratory focuses on characterizing genomic evolutionary dynamics in diffuse gliomas.
Education & Training
- Clinical Center at the National Institutes of HealthFellowship, Neurosurgical Oncology, 2010 - 2013
- University of British ColumbiaFRCSC, Residency in Neurosurgery, 2002 - 2010
- University of Texas M. D. Anderson Cancer CenterMS, Cancer Biology, 2006 - 2008
- University of Calgary Faculty of MedicineClass of 2002, MD
Certifications & Licensure
- NY State Medical License 2013 - 2026
- Royal College of Physicians and Surgeons of CanadaNeurosurgery
Awards, Honors, & Recognition
- American Brain Tumor Association Young Investigator Award AANS/CNS Section on Tumors
- Preuss Award for Basic Neurosurgical Research AANS/CNS Section on Tumors
Publications & Presentations
PubMed
- 8 citationsEmerging interplay of genetics and epigenetics in gliomas: a new hope for targeted therapy.Raymund Yong, Nadejda M. Tsankova
Seminars in Pediatric Neurology. 2015-03-01 - 1 citationsWhat is the cognitive footprint of insular glioma?Noah M Nichols, Bahie Ezzat, Allison C Waters, Fedor Panov, Raymund L Yong
Frontiers in Human Neuroscience. 2024-01-01 - 173 citationsHuman bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Δ24-RGD to human gliomasRaymund L. Yong, Naoki Shinojima, Juan Fueyo, Joy Gumin, Giacomo G. Vecil
Cancer Research. 2009-12-01
Journal Articles
- Review Comparison of Glioblastoma (GBM) Molecular Classification MethodsRaymund Yong, MD, ScienceDirect
Press Mentions
- Mount Sinai & Sema4 Scientists Identify Biomarker for Progression and Drug Response in Brain CancerOctober 16th, 2017
- Mount Sinai, Sema4 Data Scientists Tout Brain Cancer BreakthroughOctober 16th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: